Perceptive Informatics Enhances Medical Imaging Capabilities for Assessment of Cardiac Function
Company integrates leading medical imaging technology with image management and reporting system provided by Digisonics.
Boston, MA-June 2, 2008-Perceptive Informatics, the technology subsidiary of PAREXEL International Corporation, today announced that it has integrated its leading medical imaging technology with the functionality of DigiView, a specialized image management and reporting system provided by Digisonics, to offer clients expanded capabilities for cardiac function assessment in clinical studies. The system provides high-performance electronic review, analysis, reporting, and archiving of medical images related to cardiac function assessment. Cardiac function assessment is required for a broad range of therapeutic area research, including cardiology, oncology, central nervous system, and metabolism/endocrinology studies.
As cardiac safety has become a greater regulatory focus for various compounds, biopharmaceutical companies increasingly turn to us for cardiac evaluations to support the demonstration of safety and efficacy," said Todd A. Joron, corporate vice president and general manager of Perceptive Informatics at PAREXEL International. "By combining this tool with our leading medical imaging technology and in-depth expertise, we are able to help clients better meet their cardiovascular imaging needs."
The integrated Perceptive and DigiView system, which supports various cardiovascular imaging modalities, provides several capabilities, including faster, more accurate review of cardiac images as well as automatic synchronization of image analysis findings with other clinical data through an electronic Case Report Form. The system provides an electronic record of all image analysis versions and exceeds HIPAA requirements for providing security and a regulatory audit trail, as well as capturing electronic signatures. Perceptive Informatics' medical imaging technology is fully validated and in compliance with regulatory guidelines.
The Perceptive Informatics Medical Imaging division leverages advanced technology to help ensure the effective use of imaging surrogate endpoint data as well as secure data access and back-up. The Perceptive Informatics medical imaging team operates globally and services a wide range of therapeutic areas, including oncology, central nervous system, musculoskeletal, cardiovascular, and metabolism/endocrinology.
Unifying Industry to Better Understand GCP Guidance
May 7th 2025In this episode of the Applied Clinical Trials Podcast, David Nickerson, head of clinical quality management at EMD Serono; and Arlene Lee, director of product management, data quality & risk management solutions at Medidata, discuss the newest ICH E6(R3) GCP guidelines as well as how TransCelerate and ACRO have partnered to help stakeholders better acclimate to these guidelines.
FDA Grants Priority Review to Merck’s sBLA for Winrevair After Early Success in ZENITH PAH Trial
July 2nd 2025Merck’s bid to update Winrevair’s label advances with FDA priority review, backed by Phase III ZENITH data showing a 76% reduction in major morbidity and mortality events in patients with pulmonary arterial hypertension.
